搜索优化
English
全部
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
搜索
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按相关度排序
按时间排序
5 天
K药遇到了新麻烦
当癌症治疗趋向慢性病管理,皮下制剂正在成为必争之地。Halozyme的狙击也让我们看到,K药在面对生物类似药的冲击、GLP-1药物的跨界挑战,以及后来者的头对头PK挑战之外的“另类”风险: ...
新浪网
5 天
K药遇到了新麻烦
还有曲妥珠单抗皮下注射剂 Herceptin Hylecta和曲妥珠+帕妥珠复方皮下制剂Phesgo,其中Phesgo自上市以来也保持着增长态势。 从历史进程来看,PD-1从静脉 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Deportation order blocked
US launches strikes in Yemen
SK: Massive rallies erupt
Withdraws nomination
RU, UKR launch attacks
Permanently shuts route
Top intelligence agency visit
Laceration hazard recall
Felony gun possession arrest
US expels SA ambassador
Wins longest-ever Iditarod
Consumer sentiment drops
Strikes deal with DOGE
Cuba suffers power outage
Gold rises to new heights
Second protester arrested
Severe weather outbreak
Child abuse images sentence
ISIS leader killed in Iraq
‘Ted Lasso’ is coming back
Chiefs sign Tillery
Kupp signs with Seahawks
Coffee creamer recall
Sworn in as Canada's PM
Syed formally resentenced
To cut 2,000+ jobs
Influencer leaves Australia
Texas measles outbreak
Pleads not guilty
Influential WY senator dies
Plane engine catches fire
反馈